336 related articles for article (PubMed ID: 33611140)
1. Peptide-targeted dendrimeric prodrugs of 5-aminolevulinic acid: A novel approach towards enhanced accumulation of protoporphyrin IX for photodynamic therapy.
Tewari KM; Dondi R; Yaghini E; Pourzand C; MacRobert AJ; Eggleston IM
Bioorg Chem; 2021 Apr; 109():104667. PubMed ID: 33611140
[TBL] [Abstract][Full Text] [Related]
2. Zwitterionic stealth peptide-capped 5-aminolevulinic acid prodrug nanoparticles for targeted photodynamic therapy.
Wu J; Lin Y; Li H; Jin Q; Ji J
J Colloid Interface Sci; 2017 Jan; 485():251-259. PubMed ID: 27676086
[TBL] [Abstract][Full Text] [Related]
3. Poly(L-histidine)-tagged 5-aminolevulinic acid prodrugs: new photosensitizing precursors of protoporphyrin IX for photodynamic colon cancer therapy.
Johnson RP; Chung CW; Jeong YI; Kang DH; Suh H; Kim I
Int J Nanomedicine; 2012; 7():2497-512. PubMed ID: 22679363
[TBL] [Abstract][Full Text] [Related]
4. Activity of phosphatase-sensitive 5-aminolevulinic acid prodrugs in cancer cell lines.
Herceg V; Lange N; Allémann E; Babič A
J Photochem Photobiol B; 2017 Jun; 171():34-42. PubMed ID: 28472723
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic anticancer activity evaluation of novel 5-aminolevulinic acid and 3-hydroxypyridinone conjugates.
Zhang J; Yuan S; Fan M; Wang K; Guo J; Zang A; Ren J; Su W; Zhang C; Xie Y
Bioorg Med Chem; 2024 May; 105():117726. PubMed ID: 38626642
[TBL] [Abstract][Full Text] [Related]
6. Improving in vitro photodynamic therapy through the development of a novel iron chelating aminolaevulinic acid prodrug.
Curnow A; Perry A; Wood M
Photodiagnosis Photodyn Ther; 2019 Mar; 25():157-165. PubMed ID: 30553949
[TBL] [Abstract][Full Text] [Related]
7. [5-Aminolevulinic acid esters based photodynamic therapy].
Zhang S; Zhang Z; Jiang D
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2002 Jun; 19(2):310-4. PubMed ID: 12224308
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of new 5-aminolevulinic acid derivatives as prodrugs of protoporphyrin for photodynamic therapy.
Zhu W; Gao YH; Song CH; Lu ZB; Namulinda T; Han YP; Yan YJ; Wang LX; Chen ZL
Photochem Photobiol Sci; 2017 Nov; 16(11):1623-1630. PubMed ID: 28933502
[TBL] [Abstract][Full Text] [Related]
9. 5-Aminolaevulinic acid peptide prodrugs enhance photosensitization for photodynamic therapy.
Bourré L; Giuntini F; Eggleston IM; Wilson M; MacRobert AJ
Mol Cancer Ther; 2008 Jun; 7(6):1720-9. PubMed ID: 18566243
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of ABCG2 transporter by lapatinib enhances 5-aminolevulinic acid-mediated protoporphyrin IX fluorescence and photodynamic therapy response in human glioma cell lines.
Mansi M; Howley R; Chandratre S; Chen B
Biochem Pharmacol; 2022 Jun; 200():115031. PubMed ID: 35390338
[TBL] [Abstract][Full Text] [Related]
11. Small molecule kinase inhibitors enhance aminolevulinic acid-mediated protoporphyrin IX fluorescence and PDT response in triple negative breast cancer cell lines.
Palasuberniam P; Kraus D; Mansi M; Howley R; Braun A; Myers K; Chen B
J Biomed Opt; 2021 Sep; 26(9):. PubMed ID: 34545713
[TBL] [Abstract][Full Text] [Related]
12. Design and Proof of Programmed 5-Aminolevulinic Acid Prodrug Nanocarriers for Targeted Photodynamic Cancer Therapy.
Wu J; Han H; Jin Q; Li Z; Li H; Ji J
ACS Appl Mater Interfaces; 2017 May; 9(17):14596-14605. PubMed ID: 28397487
[TBL] [Abstract][Full Text] [Related]
13. A quantitative assessment of protoporphyrin IX metabolism and phototoxicity in human skin following dose-controlled delivery of the prodrugs 5-aminolaevulinic acid and 5-aminolaevulinic acid-n-pentylester.
Gerscher S; Connelly JP; Beijersbergen Van Henegouwen GM; MacRobert AJ; Watt P; Rhodes LE
Br J Dermatol; 2001 May; 144(5):983-90. PubMed ID: 11359385
[TBL] [Abstract][Full Text] [Related]
14. 5-Aminolevulinic acid (ALA)-induced protoporphyrin IX fluorescence and photodynamic effects in the rat bladder: an in vivo study comparing oral and intravesical ALA administration.
Chang SC; Buonaccorsi G; MacRobert AJ; Bown SG
Lasers Surg Med; 1997; 20(3):254-64. PubMed ID: 9138254
[TBL] [Abstract][Full Text] [Related]
15. Novel prodrug approach to photodynamic therapy: Fmoc solid-phase synthesis of a cell permeable peptide incorporating 5-aminolaevulinic acid.
Dixon MJ; Bourré L; MacRobert AJ; Eggleston IM
Bioorg Med Chem Lett; 2007 Aug; 17(16):4518-22. PubMed ID: 17587577
[TBL] [Abstract][Full Text] [Related]
16. Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporphyrin.
Kloek J; Akkermans W; Beijersbergen van Henegouwen GM
Photochem Photobiol; 1998 Jan; 67(1):150-4. PubMed ID: 9477773
[TBL] [Abstract][Full Text] [Related]
17. Targeting ABCG2 transporter to enhance 5-aminolevulinic acid for tumor visualization and photodynamic therapy.
Chandratre S; Olsen J; Howley R; Chen B
Biochem Pharmacol; 2023 Nov; 217():115851. PubMed ID: 37858868
[TBL] [Abstract][Full Text] [Related]
18. An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy.
Anayo L; Magnussen A; Perry A; Wood M; Curnow A
Lasers Surg Med; 2018 Jul; 50(5):552-565. PubMed ID: 29603761
[TBL] [Abstract][Full Text] [Related]
19. Aminolevulinic acid derivatives-based photodynamic therapy in human intra- and extrahepatic cholangiocarcinoma cells.
Chung CW; Kim CH; Lee HM; Kim DH; Kwak TW; Chung KD; Jeong YI; Kang DH
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):503-10. PubMed ID: 23429232
[TBL] [Abstract][Full Text] [Related]
20. Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines.
Ji Z; Yang G; Vasovic V; Cunderlikova B; Suo Z; Nesland JM; Peng Q
J Photochem Photobiol B; 2006 Sep; 84(3):213-20. PubMed ID: 16709459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]